These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
640 related articles for article (PubMed ID: 34070217)
1. Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease. Serra M; Pinna A; Costa G; Usiello A; Pasqualetti M; Avallone L; Morelli M; Napolitano F Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070217 [No Abstract] [Full Text] [Related]
2. The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models. Napolitano F; D'Angelo L; de Girolamo P; Avallone L; de Lange P; Usiello A Neuroscience; 2018 Aug; 384():419-428. PubMed ID: 29857029 [TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia. Brugnoli A; Napolitano F; Usiello A; Morari M Neurobiol Dis; 2016 Jan; 85():155-163. PubMed ID: 26522958 [TBL] [Abstract][Full Text] [Related]
4. The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses. Napolitano F; De Rosa A; Russo R; Di Maio A; Garofalo M; Federici M; Migliarini S; Ledonne A; Rizzo FR; Avallone L; Nuzzo T; Biagini T; Pasqualetti M; Mercuri NB; Mazza T; Chambery A; Usiello A Sci Rep; 2019 Oct; 9(1):15294. PubMed ID: 31653935 [TBL] [Abstract][Full Text] [Related]
5. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Errico F; Santini E; Migliarini S; Borgkvist A; Centonze D; Nasti V; Carta M; De Chiara V; Prosperetti C; Spano D; Herve D; Pasqualetti M; Di Lauro R; Fisone G; Usiello A Mol Cell Neurosci; 2008 Feb; 37(2):335-45. PubMed ID: 18035555 [TBL] [Abstract][Full Text] [Related]
6. Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion. Ghiglieri V; Napolitano F; Pelosi B; Schepisi C; Migliarini S; Di Maio A; Pendolino V; Mancini M; Sciamanna G; Vitucci D; Maddaloni G; Giampà C; Errico F; Nisticò R; Pasqualetti M; Picconi B; Usiello A Sci Rep; 2015 Jul; 5():10933. PubMed ID: 26190541 [TBL] [Abstract][Full Text] [Related]
7. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease. Ahlers-Dannen KE; Spicer MM; Fisher RA Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009 [TBL] [Abstract][Full Text] [Related]
8. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit. Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207 [TBL] [Abstract][Full Text] [Related]
9. Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age. Costa G; Porceddu PF; Serra M; Casu MA; Schiano V; Napolitano F; Pinna A; Usiello A; Morelli M Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925704 [TBL] [Abstract][Full Text] [Related]
11. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease. Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317 [TBL] [Abstract][Full Text] [Related]
12. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Harrison LM; LaHoste GJ Neuroscience; 2006; 137(2):483-92. PubMed ID: 16352400 [TBL] [Abstract][Full Text] [Related]
13. RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum. Shahani N; Swarnkar S; Giovinazzo V; Morgenweck J; Bohn LM; Scharager-Tapia C; Pascal B; Martinez-Acedo P; Khare K; Subramaniam S Sci Signal; 2016 Nov; 9(454):ra111. PubMed ID: 27902448 [TBL] [Abstract][Full Text] [Related]
14. Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? Villalba RM; Smith Y Neuroscience; 2013 Oct; 251():2-20. PubMed ID: 23867772 [TBL] [Abstract][Full Text] [Related]
15. The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging. Pinna A; Napolitano F; Pelosi B; Di Maio A; Wardas J; Casu MA; Costa G; Migliarini S; Calabresi P; Pasqualetti M; Morelli M; Usiello A Mov Disord; 2016 Apr; 31(4):583-9. PubMed ID: 26853527 [TBL] [Abstract][Full Text] [Related]
16. Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Subramaniam S; Napolitano F; Mealer RG; Kim S; Errico F; Barrow R; Shahani N; Tyagi R; Snyder SH; Usiello A Nat Neurosci; 2011 Dec; 15(2):191-3. PubMed ID: 22179112 [TBL] [Abstract][Full Text] [Related]
17. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy. Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related]
19. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors. Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596 [TBL] [Abstract][Full Text] [Related]
20. Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease. Koski SK; Leino S; Panula P; Rannanpää S; Salminen O Neurosci Lett; 2020 Jun; 729():134932. PubMed ID: 32224226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]